Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study
Psychotherapy and Psychosomatics, Exclusive Author Commentary  Clinical Article

Fiedorowicz JG et al. – The results provide evidence that chronicity of mood symptoms contribute to vasculopathy in a dose–dependent fashion. Patients with more manic/hypomanic symptoms had poorer endothelial function. First–generation antipsychotic exposure was associated with arterial stiffness, evidenced by higher augmentation pressure, perhaps secondary to elevated blood pressure. Vascular phenotyping methods may provide a promising means of elucidating the mechanisms linking mood disorders to vascular disease.

Methods
  • Participants with mood disorders were recruited for the National Institute of Mental Health Collaborative Depression Study (CDS) and followed prospectively.
  • A cross-sectional metabolic and vascular function evaluation was performed on a sub-sample near completion after a mean follow-up of 27 years.

Results
  • A total of 35 participants from the University of Iowa (33) and Washington University (2) sites of the CDS consented to a metabolic and vascular function assessment at the Iowa site.
  • In multivariate linear regression, controlling for age, gender, and smoking, manic/hypomanic, but not depressive, symptom burden was associated with lower flow-mediated dilation.
  • Cumulative exposure to antipsychotics and mood stabilizers was associated with elevated augmentation pressure and mean aortic systolic blood pressure.
  • This appeared specifically related to first-generation antipsychotic exposure and mediated by increases in brachial systolic pressure.
  • Although second-generation antipsychotics were associated with dyslipidemia and insulin resistance, they were not associated with vasculopathy.

In a prior analysis of 435 individuals with bipolar disorder from the Collaborative Depression Study (CDS), we found manic/hypomanic symptom burden (chronicity of clinically significant manic/hypomanic symptomatology) was significantly associated with cardiovascular mortality (Fiedorowicz et al. Psychosom Med 2009). This appeared to account for the greater risk of cardiovascular mortality in bipolar I, relative to bipolar II disorder as observed in the CDS sample and the only prior study to assess mortality differences by bipolar subtype (Angst F et al. J Affect Disord 1994). We were interested in replicating and extending the prior finding. To do so, we recruited a small subset of participants from the CDS, whose course of illness had been prospectively assessed for over a quarter century through participation, for a quantitative metabolic and vascular phenotyping assessment. We analogously found a dose-response relationship between manic/hypomanic symptom burden and endothelial dysfunction, based on a relationship with poorer flow-mediated but not nitroglycerin-mediated vasodilation. While difficult to study as reliable data is seldom available, the assessment of a dose-response between the long-term chronicity of illness and vascular outcomes circumvents some of the issues related to selection bias in case control studies (e.g. inpatient registry compared to national data) and provides additional evidence for a causal relationship between bipolar disorder and vascular disease. Such methods may assist in the identification of the most relevant mechanisms mediating the well-established relationship between bipolar disorder and vascular mortality (reviewed by Murray et al. Curr Psychiatry Rep 2009; Weiner M et al. Ann Clin Psychiatry 2011). References: Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-81. Fiedorowicz JG, Coryell WH, Rice JP, Warren LL, Haynes WG. Vasculopathy Related to Manic/Hypomanic Symptom Burden and First-Generation Antipsychotics in a Sub-Sample from the Collaborative Depression Study. Psychotherapy and Psychosomatics 2012;81:235-43. Fiedorowicz JG, Solomon DA, Endicott J, Leon AC, Li C, Rice JP, et al. Manic/hypomanic symptom burden and cardiovascular mortality in bipolar disorder. Psychosom Med 2009;71:598-606. Murray DP, Weiner M, Prabhakar M, Fiedorowicz JG. Mania and mortality: why the excess cardiovascular risk in bipolar disorder? Curr Psychiatry Rep 2009;11:475-80. Weiner M, Warren L, Fiedorowicz JG. Cardiovascular morbidity and mortality in bipolar disorder. Ann Clin Psychiatry 2011;23:40-7.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Psychiatry

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Psychiatry Articles

1 Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: A nationwide register-based cohort study in Denmark CNS Drugs, June 18, 2014    Clinical Article

2 Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: A multiple-treatments meta-analysis FOCUS, June 16, 2014    Evidence Based Medicine

3 Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials Psychosomatic Medicine, March 20, 2014    Evidence Based Medicine    Review Article    Clinical Article

4 Re-evaluating the role of antidepressants in cancer-related depression: A systematic review and meta-analysis General Hospital Psychiatry, June 4, 2014    Evidence Based Medicine

5 Does pharmacological treatment of ADHD in adults enhance parenting performance?: Results of a double-blind randomized trial CNS Drugs, June 12, 2014    Clinical Article

6 Association between C-reactive protein and depression: modulated by gender and mediated by body weight Psychiatry Research, June 19, 2014    Clinical Article

7 A comparison of the effects of hatha yoga and resistance exercise on mental health and well-being in sedentary adults: A pilot study Complementary Therapies in Medicine, June 20, 2014    Clinical Article

8 Attachment anxiety is related to epstein-barr virus latency Brain, Behavior, and Immunity, June 23, 2014    Clinical Article

9 Pretreatment brain states identify likely nonresponse to standard treatments for depression Biological Psychiatry, May 23, 2014    Clinical Article

10 Physical diseases among persons with obsessive compulsive symptoms and disorder: A general population study Social Psychiatry and Psychiatric Epidemiology, June 13, 2014    Clinical Article

11 Efficacy of adjunctive aripiprazole in patients with major depressive disorder whose symptoms worsened with antidepressant monotherapy CNS Spectrums, May 30, 2014    Clinical Article

12 Drug treatment for attention-deficit/hyperactivity disorder and suicidal behaviour: register based study BMJ, June 24, 2014    Evidence Based Medicine    Clinical Article

13 A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan war veterans American Journal of Psychiatry, June 9, 2014    Clinical Article

14 A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population- A meta-analysis of 31 studies Full Text BMC Psychiatry, May 20, 2014    Free full text    Evidence Based Medicine    Clinical Article

15 Predicting autism diagnosis by 7 years of age using parent report of infant social communication skills Journal of Paediatrics and Child Health, June 10, 2014    Clinical Article

16 Risk of myocardial infarction and stroke in bipolar disorder: A systematic review and exploratory meta-analysis Acta Psychiatrica Scandinavica, June 2, 2014    Evidence Based Medicine    Review Article

17 Myofascial pain in war veterans with post-traumatic stress disorder Journal of Musculoskeletal Pain , June 11, 2014    Clinical Article

18 Topiramate as an adjuvant treatment for obsessive compulsive symptoms in patients with bipolar disorder: A randomized double blind placebo controlled clinical trial Journal of Affective Disorders, June 9, 2014    Clinical Article

19 Elevated fetal steroidogenic activity in autism Full Text Molecular Psychiatry, June 25, 2014    Free full text    Clinical Article

20 Eveningness and insomnia: independent risk factors of nonremission in major depressive disorder SLEEP, May 7, 2014    Clinical Article

Indexed Journals in Psychiatry : Current Psychiatry, Bipolar Disorders, American Journal of Psychiatry, Addictionmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close